Skip to main content
Premium Trial:

Request an Annual Quote

Newtopia Inks Aetna Contract for Metabolic Syndrome Personalized Med Program

NEW YORK (GenomeWeb) – Following a pilot study, Newtopia has signed a contract to provide Aetna's customers with a personalized health program that utilizes genetic testing and behavioral science targeted at those with metabolic syndrome.

The Toronto-based firm had previously provided such services to around 500 Aetna employees under a pilot program designed to gauge if Newtopia's genetic testing and coaching program could reduce their risk of metabolic syndromes over the period of a year. According to Newtopia, Aetna verified that employees enrolled in the program "lost weight, reduced their waist size, and had high levels of engagement in the program."

Terms of the new contract were not disclosed.

"As we continue to work towards improving health outcomes and reducing healthcare costs for our members, Newtopia provides an opportunity for individuals to be inspired by a health engagement platform that allows them to develop healthy habits to meet their own unique lifestyles," Greg Steinberg, head of clinical innovation at Aetna, said in a statement.

The Scan

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.